This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

George H. Bresnick

Arch Ophthalmol. 1988;106(3):324-326.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The correct identification of eyes with central retinal vein occlusion (CRVO) that are at high risk for developing iris neovascularization is of great importance in managing this potentially blinding disorder. Iris neovascularization can lead rapidly to neovascular glaucoma; panretinal photocoagulation of eyes with iris new vessels may cause regression of the new vessels and prevent the development of glaucoma.^1-3 As with the growth of retinal or disc new vessels in the proliferative retinopathies, the growth of iris new vessels in CRVO is probably caused by a neovasculogenesis factor released by poorly perfused (ischemic) retina.⁴ This concept is supported by a number of fluorescein angiographic studies^5-9 demonstrating that eyes with CRVO with extensive capillary nonperfusion have a relatively high rate (40% to 60% ) of developing iris new vessels, while eyes with CRVO with relatively good capillary perfusion develop iris new vessels at

See also p 348 and 353. . . . [Full Text PDF of this Article]

Author Affiliations
Madison, Wis

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?